Literature DB >> 12078025

[Cerebral toxocariasis: a rare cause of cognitive disorders. A contribution to differential dementia diagnosis].

E Richartz1, G Buchkremer.   

Abstract

We report on a 65-year-old woman with depressive symptoms and cognitive deficits confirmed by psychometric tests. Routine blood tests, serology, EEG, and cranial computed tomography (CCT) being normal, the CSF revealed an eosinophilic reaction and a positive antibody titre against Toxocara canis. After treatment with two oral courses of albendazole, the eosinophils had disappeared, whereas the antibody titre had increased. One year later, the patient's cognitive symptoms had improved, and new antibodies against toxocara were seen in the peripheral blood. This increase in antibodies represents an expected immunological reaction to the increased exposition to toxocara antigen under effective therapy. The infection might go back to the patient's youth, when she was a shepherd for several years and in close contact to dogs. A review of the literature did not yield other reports of toxocara infections leading to cognitive or other psychiatric symptoms. Taking the toxocara infection as the cause of this patient's cognitive defects, we propose that lumbar punction becomes part of the diagnostic standard in differential diagnosis of dementia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12078025     DOI: 10.1007/s001150001028

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  13 in total

Review 1.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 2.  Clinical spectrum of symptoms in cerebral Toxocariasis (Review).

Authors:  Any Docu Axelerad; Alina Zorina Stroe; Anca Elena Gogu; Agneta Pusztai; Dragos Catalin Jianu; Duta Daniel; Daniel Docu Axelerad
Journal:  Exp Ther Med       Date:  2021-03-22       Impact factor: 2.447

3.  Neurotoxocarosis alters myelin protein gene transcription and expression.

Authors:  Lea Heuer; Martin Beyerbach; Fred Lühder; Andreas Beineke; Christina Strube
Journal:  Parasitol Res       Date:  2015-03-17       Impact factor: 2.289

4.  Cerebral toxocariasis: a possible cause of epileptic seizure in children.

Authors:  Heidi Bächli; Jean Claude Minet; Otmar Gratzl
Journal:  Childs Nerv Syst       Date:  2004-05-12       Impact factor: 1.475

Review 5.  Toxocariasis and epilepsy: systematic review and meta-analysis.

Authors:  Graziella Quattrocchi; Alessandra Nicoletti; Benoit Marin; Elisa Bruno; Michel Druet-Cabanac; Pierre-Marie Preux
Journal:  PLoS Negl Trop Dis       Date:  2012-08-14

6.  Toxocara infection in psychiatric inpatients: a case control seroprevalence study.

Authors:  Cosme Alvarado-Esquivel
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

7.  Lack of Association between Toxocara Exposure and Suicide Attempts in Psychiatric Patients.

Authors:  Cosme Alvarado-Esquivel; Jesús Hernández-Tinoco; Luis Francisco Sánchez-Anguiano
Journal:  J Parasitol Res       Date:  2015-09-21

8.  Expect the unexpected: a case of isolated eosinophilic meningitis in toxocariasis.

Authors:  Christian Sick; Michael G Hennerici
Journal:  Case Rep Neurol       Date:  2014-11-12

9.  Enhanced expressions of neurodegeneration-associated factors, UPS impairment, and excess Aβ accumulation in the hippocampus of mice with persistent cerebral toxocariasis.

Authors:  Chia-Mei Chou; Yueh-Lun Lee; Chien-Wei Liao; Ying-Chieh Huang; Chia-Kwung Fan
Journal:  Parasit Vectors       Date:  2017-12-22       Impact factor: 3.876

10.  Brain injury-associated biomarkers of TGF-beta1, S100B, GFAP, NF-L, tTG, AbetaPP, and tau were concomitantly enhanced and the UPS was impaired during acute brain injury caused by Toxocara canis in mice.

Authors:  Chien-Wei Liao; Chia-Kwung Fan; Ting-Chang Kao; Dar-Der Ji; Kua-Eyre Su; Yun-Ho Lin; Wen-Long Cho
Journal:  BMC Infect Dis       Date:  2008-06-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.